Amarin Corp plc\uk cash flow statement
In fiscal 2025, Amarin Corp plc\uk's operations generated $6.7m of cash; it spent $0 on capital projects, leaving free cash flow of $6.7m.
Cash flow statement
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −190 | −75 | −84 | −72 | −33 | −95 | −9 | −22 | −67 | −180 | 7 | −31 | 7 | 37 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | — | — |
| Stock-based pay | 15 | 9 | 14 | 14 | 14 | 19 | 31 | 46 | 37 | 26 | 16 | 18 | 14 | 7 |
| Capital spending | 0 | — | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −190 | — | −84 | −72 | −33 | −95 | −12 | −22 | −67 | −180 | 7 | −31 | 7 | 37 |
| Free cash flow after stock pay | −205 | — | −98 | −85 | −47 | −114 | −43 | −68 | −103 | −206 | −9 | −49 | −7 | 30 |
| Share buybacks | — | — | 0 | — | — | — | — | — | — | — | — | — | — | — |
| Shares issued | 121 | — | — | 65 | — | 265 | 440 | — | — | — | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −13 | −12 | 17 | −13 | 15 | 6 | 7 | 9 |
| Stock-based pay | 3 | 4 | 6 | 2 | 2 | 2 | 2 | 1 |
| Capital spending | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | −13 | −12 | 17 | −13 | 15 | 6 | 7 | 9 |
| Free cash flow after stock pay | −17 | −17 | 11 | −15 | 14 | 4 | 5 | 8 |
Compare with peers
- Cronos Group Inc. cash flow
- Kamada LTD cash flow
- Biote Corp. cash flow
- Organigram Global Inc. cash flow
- Heron Therapeutics, Inc. cash flow
Head to head: AMRN vs CRONAMRN vs KMDAAMRN vs BTMDAMRN vs HRTX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies